Ticker brief
MDGL MADRIGAL PHARMACEUTICALS INC
Consumer, Non-cyclical · Pharmaceuticals
last close
$528.10
1 day
+2.7%
14 days
+4.4%
mkt cap
$12.2B
signals 14d
6
authors 14d
5
Sentiment — last 14 days
daily mean sentiment, 2026-06-24 → 2026-07-02 · now +0.25 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Quantumup1 | C | -1.95 | 2 | +0.55 |
| @Pharmdca | C | -1.50 | 1 | -0.25 |
| @CrweWorld | C | · | 1 | +0.25 |
| @AlertsAndNews | C | +1.52 | 1 | +0.30 |
| @MarketMaestro1 | C | -1.27 | 1 | +0.25 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-02 | @MarketMaestro1 | +0.25 | MDGL chart looks similar to prior RYTM setup. | — | tweet ↗ |
| 2026-07-01 | @AlertsAndNews | +0.30 | Ribo and Madrigal reach first major siRNA partnership milestone and start IND-enabling studies. | +2.7% | tweet ↗ |
| 2026-07-01 | @CrweWorld | +0.25 | Ribo and Madrigal reach a major milestone in siRNA therapies for MASH. | +2.7% | tweet ↗ |
| 2026-06-29 | @Quantumup1 | +0.55 | Piper reiterates MDGL Overweight with $900 target and bullish trial readout thesis. | +0.2% | tweet ↗ |
| 2026-06-29 | @Pharmdca | -0.25 | Trimming biotech positions and raising cash. — Author is trimming named biotech positions after sector run-up. | +0.2% | tweet ↗ |
| 2026-06-24 | @Quantumup1 | +0.55 | Piper Sandler OW $900 and bullish on REZDIFFRA launch and pipeline. | +3.6% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.